Prostate Cancer Clinical Trial

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

Summary

Determine diagnostic accuracy of Axumin-PET positive bone lesion by confirmatory bone biopsy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male
Be ≥ 18 years of age
Diagnosed with prostate cancer
Be willing and able to provide informed consent
Be informed of the investigational nature of this study

Exclusion Criteria:

Having a history of severe claustrophobia
Weight exceeding 400lbs

Study is for people with:

Prostate Cancer

Estimated Enrollment:

15

Study ID:

NCT03496844

Recruitment Status:

Completed

Sponsor:

University of Arizona

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Arizona
Tucson Arizona, 85724, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

15

Study ID:

NCT03496844

Recruitment Status:

Completed

Sponsor:


University of Arizona

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider